Myria Biosciences AG

Myria Biosciences AG is at the forefront of biotechnology research, dedicated to reshaping drug discovery through the application of synthetic intelligence. Myria Biosciences applies synthetic intelligence to engineer natural-product inspired compounds for pharmaceutical and biotechnology advancements.

The company's innovative GEMMS (Genetically Engineered Modular Molecule Scaffolds) platform integrates synthetic biology and artificial intelligence, creating a unique synthetic intelligence approach. This allows for the design and biological production of therapeutic compounds that go far beyond the limitations of natural evolution. Myria Biosciences is unlocking new chemical spaces and generating optimized molecular candidates with unprecedented speed and precision, addressing unmet medical needs effectively.

With headquarters in Basel at Hochbergerstrasse 60C, 4057, CH, and additional locations including Campus Starterzentrum, Geb. A1 2, Saarbrücken, 66123, DE, and 321-323 High Road, Office 6995, Chadwell Heath, Essex RM6 6AX, GB, Myria Biosciences AG is poised for substantial growth and commercial success. We invite the management team at Myria Biosciences AG to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.